Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo

Despite recent advances, allografting remains the only potential cure for myeloma. From July 1999 to June 2005, 100 newly diagnosed patients younger than 65 years were enrolled in a prospective multicenter study. First-line treatment included vincristin, adriamycin, and dexamethasone (VAD)–based ind...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Bruno, Benedetto, Rotta, Marcello, Patriarca, Francesca, Mattei, Daniele, Allione, Bernardino, Carnevale-Schianca, Fabrizio, Sorasio, Roberto, Rambaldi, Alessandro, Casini, Marco, Parma, Matteo, Bavaro, Pasqua, Onida, Francesco, Busca, Alessandro, Castagna, Luca, Benedetti, Edoardo, Iori, Anna Paola, Giaccone, Luisa, Palumbo, Antonio, Corradini, Paolo, Fanin, Renato, Maloney, David, Storb, Rainer, Baldi, Ileana, Ricardi, Umberto, Boccadoro, Mario
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Hematology 2009
נושאים:
Transplantation
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2665903/
https://ncbi.nlm.nih.gov/pubmed/19064724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-07-167379
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים